The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years. However, quality concerns over antibodies are the major challenge in this market.
The kits segment accounted for the highest growth rate in the Immunofluorescence assay market, by product, during the forecast period The Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories.The kits segment accounted for the highest growth rate in the Immunofluorescence assay market in 2020.
The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls, among CROs, academic institutes, and research institutes is growing, contributing to this segment’s high growth rate.
Indirect immunofluorescence segment accounted for the highest CAGR Based on type, the immunofluorescence assays market is segmented into indirect immunofluorescence and direct immunofluorescence.In 2020, indirect immunofluorescence accounted for accounted for the highest growth rate.
The major factors driving the growth of this segment are its advantages such as sensitivity, flexibility, better amplification of the signal, and lower cost over direct immunofluorescence.
Cancer segment accounted for the highest CAGR Based on disease, the immunofluorescence assays market is segmented into cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and other diseases.In 2020, the cancer segment accounted for the highest growth rate.
Increasing prevalence of cancer globally and the widespread adoption of immunofluorescence techniques for the study and diagnosis of cancer are the major factors driving this segment’s growth.
Hospitals & Diagnostic Centers segment accounted for the highest CAGR Based on end user, the immunofluorescence assays market is segmented intopharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostics centers, and contract research organizations.In 2020, the hospitals & diagnostics centers segment accounted for the highest growth rate.
This can be attributed to the rising number of cases for various diseases coupled with the increasing number of hospitals worldwide are the major driving factors for this segment’s growth.
Asia Pacific: The fastest-growing country in the Immunofluorescence assay market The Immunofluorescence assay market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.Asia Pacific is projected to register the highest CAGR during the forecast period.
Factors such as improving healthcare infrastructure, increasing healthcare spending, and favorable government initiatives are driving the growth of the immunofluorescence assay market in Asia Pacific.
The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24% • By Designation: C-level - 30%, D-level - 34%, and Others - 36% • By Region: North America- 50%, Europe- 32%, APAC-10%, RoW- 8%
Lists of Companies Profiled in the Report: • Thermo Fisher Scientific, Inc. (US) • Abcam plc (UK) • Bio-Rad Laboratories, Inc. (US) • PerkinElmer Inc. (US) • Merck KGaA (Germany) • Werfen Company (Spain) • Cell Signaling Technology, Inc. (US) • MEDIPAN GmbH (Germany) • Sino Biological, Inc. (China) • Danaher Corporation (US) • Maravai LifeSciences (US) • Enzo Biochem, Inc. (US) • Becton, Dickinson and Company (US) • Olympus Corporation (Japan) • Nikon Corporation (Japan) • Bruker Corporation (US) • Agilent Technologies (US) • Zyagen, Inc. (US) • Cellabs (Australia) • J. Mitra & Co. Pvt. Ltd. (India) • Abnova Corporation (Taiwan) • EpiGentek Group (US) • Elabscience, Inc. (US) • AESKU GROUP GmbH (Germany) • MaxVision Biosciences Inc. (Canada)
Research Coverage: This report provides a detailed picture of the Immunofluorescence assay market.It aims at estimating the size and future growth potential of the market across different segments, such as the product, type, disease, end user, and region.
The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Immunofluorescence assay market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
Our reports have been used by over 10K customers, including:
The corporate wellness market is projected to register a CAGR of 5.92% during the forecast period, with a revenue of approximately USD 52,703.51 million in 2020. It is expected to reach USD 72,728.72 million by 2026. Due to the impact of COVID-19, it was found that people with chronic diseases, including diabetes, high blood pressure,...
The North American radiation protection aprons market is projected to reach USD 48 million by 2026 from USD 35 million in 2021, at a CAGR of 6.9% during the forecast period. The growth of the North American radiation protection aprons market is being driven by factors such as increasing number of trained radiologic technologists, increasing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Disinfectants and Sanitizers Market Report The healthcare disinfectants and sanitizers market by revenue is expected to grow at a CAGR of 10.89% during the period 2022–2027. In 2021, disinfectants accounted for the major share...
Executive Summary The Global Transcatheter Tricuspid Valve Intervention (TTVI) market is projected to display noteworthy growth and estimated to reach value of USD 10.17 billion by the year 2030 with Europe region leading the regional market share. Demand for transcatheter valvular therapeutics for tricuspid valve diseases...
301 pages •
By The Business Research Company
• Oct 2021
Synthetic Biology Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global synthetic biology market as it emerges from the COVID 19 shut down. Description: Where is the largest...
The global wearable healthcare devices market is projected to reach USD 30.1 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 13.2% during the forecast period. Market growth is driven by factors such as the development of technologically advanced products and robust penetration of 3G and 4G networks for uninterrupted healthcare...
The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period. The growth in this market is driven by the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing...
The global medical isolation gowns market is expected to reach US$ 3,542.78 million by 2028 from US$ 1,346.31 million in 2021; it is estimated to grow at a CAGR of 14.8% from 2021 to 2028. Key factors such as increasing awareness regarding hospital-acquired infections and rising emergency procedures drive the growth of the global medical...
The global cold plasma market size is expected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 15.0% during the forecast period. The growth in this market is primarily attributed to the benefits of cold plasma, such as its environment-friendliness, increasing use of cold plasma in wound healing and cancer treatment,...
Global Powered Surgical Instrument Market is registering a CAGR of nearly 4.41% during the forecast period. An increasing number of surgical procedures, coupled with technological advancements, such as the introduction of robot-assisted surgical procedures, is expected to drive the growth of the powered surgical instrument market. In addition,...
Surgical Procedures Performed
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.